Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Apr;50(2):101-30.
doi: 10.1053/j.seminhematol.2013.03.025.

Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models

Review

Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models

Andre Larochelle et al. Semin Hematol. 2013 Apr.

Abstract

The modern laboratory mouse has become a central tool for biomedical research with a notable influence in the field of hematopoiesis. Application of retroviral-based gene transfer approaches to mouse hematopoietic stem cells (HSCs) has led to a sophisticated understanding of the hematopoietic hierarchy in this model. However, the assumption that gene transfer methodologies developed in the mouse could be similarly applied to human HSCs for the treatment of human diseases left the field of gene therapy in a decade-long quandary. It is not until more relevant humanized xenograft mouse models and phylogenetically related large animal species were used to optimize gene transfer methodologies that unequivocal clinical successes were achieved. However, the subsequent reporting of severe adverse events in these clinical trials casted doubts on the predictive value of conventional pre-clinical testing, and encouraged the development of new assays for assessing the relative genotoxicity of various vector designs.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Approach for the genetic manipulation of hematopoietic stem cells (HSCs)
The upper panel compares the predictive value and accessibility of various preclinical models in the evaluation of gene transfer efficiency and insertional genotoxicity of vectors used in HSC gene therapy trials. The lower panel depicts the optimized protocol for transduction of hematopoietic stem and progenitor cells, as used in recent clinical trials. BM (bone marrow); Flt3L (fms-related tyrosine kinase 3 ligand); FN (fibronectin); IL3 (interleukin 3); MGDF (megakaryocyte growth and development factor); MLV (murine leukemia virus); MPBC (mobilized peripheral blood cells); SCF (stem cell factor); SIN (self-inactivating); TPO (thrombopoietin)
Figure 2
Figure 2. Timeline for the development of human gene therapy protocols targeting hematopoietic stem cells (HSCs)
The main phases in the evolution of HSC gene therapy clinical trials are ordered chronologically. The six principal features defining each phase are outlined. ADA (adenosine deaminase); ALD (adrenoleukodystrophy); BM (bone marrow); CB (cord blood); CGD (chronic granulomatous disease); Flt3L (fms-related tyrosine kinase 3 ligand); FN (fibronectin); HIV (human immunodeficiency virus); IL3 (interleukin 3); IL6 (interleukin 6); LSK (Lin, Sca1+, Kit+); MGDF (megakaryocyte growth and development factor); MPBC (mobilized peripheral blood cells); SCF (stem cell factor); SCID (severe combined immunodeficiency disease); TPO (thrombopoietin); WAS (Wiskott-Aldrich syndrome)

Similar articles

Cited by

References

    1. Becker AJ, McCulloch EA, Till JE. Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature. 1963;197:452–454. - PubMed
    1. Till JE, McCulloch EA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 1961;14:213–222. - PubMed
    1. Larochelle A, Dunbar CE. Genetic manipulation of hematopoietic stem cells. Semin. Hematol. 2004;41:257–271. - PubMed
    1. Micklem HS, Ford CE, Evans EP, Gray J. Interrelationships of myeloid and lymphoid cells: studies with chromosome-marked cells transfused into lethally irradiated mice. Proc. R. Soc. Lond B Biol. Sci. 1966;165:78–102. - PubMed
    1. Abramson S, Miller RG, Phillips RA. The identification in adult bone marrow of pluripotent and restricted stem cells of the myeloid and lymphoid systems. J. Exp. Med. 1977;145:1567–1579. - PMC - PubMed